{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:13:59Z","timestamp":1791850439829,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1124\/dmd.119.089516","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T22:45:14Z","timestamp":1574808314000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9860-1979","authenticated-orcid":false,"given":"Yasuo","family":"Uchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"\u0141uczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Tachikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.119.089516_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2826.2001.00705.x","article-title":"Action of glucocorticoids on survival of nerve cells: promoting neurodegeneration or neuroprotection?","volume":"13","author":"Abrah\u00e1m","year":"2001","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/dmd.119.089516_bib2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/npp.2012.253","article-title":"Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis","volume":"38","author":"Anacker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/dmd.119.089516_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fphys.2013.00344","article-title":"Polarization of membrane associated proteins in the choroid plexus epithelium from normal and slc4a10 knockout mice","volume":"4","author":"Christensen","year":"2013","journal-title":"Front Physiol"},{"key":"10.1124\/dmd.119.089516_bib4","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1124\/dmd.115.067694","article-title":"The complexities of interpreting reversible elevated serum creatinine levels in drug development: does a correlation with inhibition of renal transporters exist?","volume":"44","author":"Chu","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089516_bib5","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1046\/j.1523-1755.2001.59780077.x","article-title":"Endogenous guanidino compounds as uremic neurotoxins","volume":"78","author":"De Deyn","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1124\/dmd.119.089516_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1471-4159.2005.03550.x","article-title":"Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier","volume":"96","author":"Deguchi","year":"2006","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.119.089516_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/0024-3205(66)91026-5","article-title":"Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid","volume":"5","author":"Guldberg","year":"1966","journal-title":"Life Sci"},{"key":"10.1124\/dmd.119.089516_bib8","doi-asserted-by":"crossref","unstructured":"Hoshi Y, Uchida Y, Tachikawa M, Ohtsuki S, Couraud PO, Suzuki T, Terasaki T (2019) Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood-brain barrier. J Cereb Blood Flow Metab DOI: 10.1177\/0271678X18822801 [published ahead of print].","DOI":"10.1177\/0271678X18822801"},{"key":"10.1124\/dmd.119.089516_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jnc.13960","article-title":"Actin filament-associated protein 1 (AFAP-1) is a key mediator in inflammatory signaling-induced rapid attenuation of intrinsic P-gp function in human brain capillary endothelial cells","volume":"141","author":"Hoshi","year":"2017","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.119.089516_bib10","doi-asserted-by":"crossref","first-page":"e12390","DOI":"10.1111\/jpi.12390","article-title":"Human transporters, PEPT1\/2, facilitate melatonin transportation into mitochondria of cancer cells: an implication of the therapeutic potential","volume":"62","author":"Huo","year":"2017","journal-title":"J Pineal Res"},{"key":"10.1124\/dmd.119.089516_bib11","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1124\/dmd.107.016220","article-title":"Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid","volume":"35","author":"Kaddoumi","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089516_bib12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","article-title":"Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC\/MS\/MS method combined with novel in-silico peptide selection criteria","volume":"25","author":"Kamiie","year":"2008","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.089516_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2045-8118-8-26","article-title":"Choroid plexus transport: gene deletion studies","volume":"8","author":"Keep","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1124\/dmd.119.089516_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/jpet.111.180398","volume":"339","author":"Kodaira","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.089516_bib15","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1002\/jps.24398","article-title":"Quantitative determination of luminal and abluminal membrane distributions of transporters in porcine brain capillaries by plasma membrane fractionation and quantitative targeted proteomics","volume":"104","author":"Kubo","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.119.089516_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0026-0495(92)90213-T","article-title":"Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals","volume":"41","author":"Marescau","year":"1992","journal-title":"Metabolism"},{"key":"10.1124\/dmd.119.089516_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.WCB.0000050062.57184.75","article-title":"Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells","volume":"23","author":"Mori","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/dmd.119.089516_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00228-014-1770-2","article-title":"N1-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction","volume":"71","author":"M\u00fcller","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.119.089516_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/mp3004308","article-title":"Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC\/D3 as a human blood-brain barrier model","volume":"10","author":"Ohtsuki","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089516_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/dmd.111.042259","article-title":"Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities","volume":"40","author":"Ohtsuki","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089516_bib21","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1002\/jps.22612","article-title":"Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects","volume":"100","author":"Ohtsuki","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.119.089516_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2013.04.006","article-title":"A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells","volume":"1521","author":"Patabendige","year":"2013","journal-title":"Brain Res"},{"key":"10.1124\/dmd.119.089516_bib23","doi-asserted-by":"crossref","first-page":"e0118638","DOI":"10.1371\/journal.pone.0118638","article-title":"Validation of a P-glycoprotein (P-gp) humanized mouse model by integrating selective absolute quantification of human MDR1, mouse Mdr1a and Mdr1b protein expressions with in vivo functional analysis for blood-brain barrier transport","volume":"10","author":"Sadiq","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/dmd.119.089516_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-079X.1989.tb00416.x","article-title":"Evidence of high concentrations of melatonin in lateral ventricular cerebrospinal fluid of sheep","volume":"6","author":"Shaw","year":"1989","journal-title":"J Pineal Res"},{"key":"10.1124\/dmd.119.089516_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/dmd.117.077586","article-title":"Discovery and validation of pyridoxic acid and homovanillic acid as novel endogenous plasma biomarkers of organic anion transporter (OAT) 1 and OAT3 in cynomolgus monkeys","volume":"46","author":"Shen","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089516_bib26","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1158\/0008-5472.CAN-09-0700","article-title":"Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid","volume":"69","author":"Shen","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.119.089516_bib27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1471-4159.2008.05641.x","article-title":"The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process","volume":"107","author":"Tachikawa","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.119.089516_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2007.04.010","article-title":"Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions\/H+-organic cation antiporters","volume":"74","author":"Tanihara","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.089516_bib29","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11095-006-9016-3","article-title":"Molecular cloning, functional characterization and tissue distribution of rat H+\/organic cation antiporter MATE1","volume":"23","author":"Terada","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.089516_bib30","series-title":"Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches","first-page":"685","article-title":"Appendix: primer on central nervous system structure\/function and the vasculature, ventricular system, and fluids of the brain","author":"Thorne","year":"2014"},{"key":"10.1124\/dmd.119.089516_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.dmpk.2014.11.002","article-title":"Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks","volume":"30","author":"Uchida","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.119.089516_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.119.089516_bib33","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s12035-018-1207-5","article-title":"Involvement of claudin-11 in disruption of blood-brain, -spinal cord, and -arachnoid barriers in multiple sclerosis","volume":"56","author":"Uchida","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1124\/dmd.119.089516_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-10-21","volume":"10","author":"Uchida","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1124\/dmd.119.089516_bib35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jnc.13147","article-title":"Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen","volume":"134","author":"Uchida","year":"2015","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.119.089516_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1749-6632.2011.06345.x","article-title":"Animal models got you puzzled?: think pig","volume":"1245","author":"Walters","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/dmd.119.089516_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocn.2004.10.002","article-title":"Autotoxicity, methylation and a road to the prevention of Parkinson\u2019s disease","volume":"12","author":"Williams","year":"2005","journal-title":"J Clin Neurosci"},{"key":"10.1124\/dmd.119.089516_bib38","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1021\/acs.molpharmaceut.9b00005","article-title":"Organic anion-transporting polypeptide 1a4 (Oatp1a4\/Slco1a4) at the blood-arachnoid barrier is the major pathway of sulforhodamine-101 clearance from cerebrospinal fluid of rats","volume":"16","author":"Yaguchi","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089516_bib39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/dmd.112.050344","article-title":"Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier","volume":"41","author":"Yasuda","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089516_bib40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/acs.molpharmaceut.7b00852","article-title":"Drug clearance from cerebrospinal fluid mediated by organic anion transporters 1 (Slc22a6) and 3 (Slc22a8) at arachnoid membrane of rats","volume":"15","author":"Zhang","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089516_bib41","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1021\/acs.molpharmaceut.7b00493","article-title":"Inner blood-retinal barrier dominantly expresses breast cancer resistance protein: comparative quantitative targeted absolute proteomics study of CNS barriers in pig","volume":"14","author":"Zhang","year":"2017","journal-title":"Mol Pharm"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624078140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624078140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.089516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:23:43Z","timestamp":1739957023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624078140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0090955624078140"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.089516","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.089516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}